OSPREY PHARMACEUTICALS USA, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.ospreypharma.com
Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Phase 1
Terminated
- Conditions
- IGA NephropathyProteinuria
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2010-06-02
- Lead Sponsor
- Osprey Pharmaceuticals USA, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00856674
- Locations
- 🇨🇦
Eastern Health, HSC, Memorial University, St. John's, Newfoundland and Labrador, Canada
🇨🇦Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦Hoptial Maisonneuve-Rosemont, Montreal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath